- Home
- GCBC vs ESPR Comparison
GCBC vs ESPR Comparison
Compare GCBC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCBC
- ESPR
- Stock Information
- Founded
- GCBC 1889
- ESPR 2008
- Country
- GCBC United States
- ESPR United States
- Employees
- GCBC N/A
- ESPR N/A
- Industry
- GCBC Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- GCBC Finance
- ESPR Health Care
- Exchange
- GCBC Nasdaq
- ESPR Nasdaq
- Market Cap
- GCBC 364.4M
- ESPR 305.0M
- IPO Year
- GCBC 1998
- ESPR 2013
- Fundamental
- Price
- GCBC $21.43
- ESPR $0.93
- Analyst Decision
- GCBC
- ESPR Buy
- Analyst Count
- GCBC 0
- ESPR 7
- Target Price
- GCBC N/A
- ESPR $6.07
- AVG Volume (30 Days)
- GCBC 66.3K
- ESPR 5.5M
- Earning Date
- GCBC 04-29-2025
- ESPR 05-06-2025
- Dividend Yield
- GCBC 1.69%
- ESPR N/A
- EPS Growth
- GCBC N/A
- ESPR N/A
- EPS
- GCBC 1.54
- ESPR N/A
- Revenue
- GCBC $65,848,000.00
- ESPR $332,314,000.00
- Revenue This Year
- GCBC N/A
- ESPR $5.17
- Revenue Next Year
- GCBC N/A
- ESPR N/A
- P/E Ratio
- GCBC $13.47
- ESPR N/A
- Revenue Growth
- GCBC N/A
- ESPR 185.66
- 52 Week Low
- GCBC $20.00
- ESPR $0.82
- 52 Week High
- GCBC $37.25
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- GCBC 38.89
- ESPR 28.01
- Support Level
- GCBC $20.62
- ESPR $0.82
- Resistance Level
- GCBC $21.95
- ESPR $1.06
- Average True Range (ATR)
- GCBC 1.26
- ESPR 0.10
- MACD
- GCBC 0.04
- ESPR -0.02
- Stochastic Oscillator
- GCBC 40.40
- ESPR 17.98
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.